Post-Pandemic Resiliency: The Shift Toward Domestic Outsourcing
The global health crisis of the early 2020s exposed the vulnerabilities of overly extended supply chains, leading many European pharmaceutical companies to rethink their outsourcing strategies. There is a growing trend toward "nearshoring" or domestic outsourcing, where trials are kept within Europe rather than being moved to lower-cost regions in Asia. This shift is driven by a desire for...
0 Reacties
0 aandelen
1011 Views
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt